At the end of the morning plenary, the Chair announced that the SCCR would continue in an informal setting:
Good afternoon, and thank you very much, sir.
I wanted to refer to the rights to be granted in this proposed treaty and I would like to give you an example of something that has recently happened in Colombia and how sometimes the retransmission rights can be abused.
At the Standing Committee on Copyright and Related Rights Twenty-seventh Session in Geneva (April 28 to May 2, 2014) the discussions on the proposed broadcasting treaty included the following safeguard articles that are totally missing from today's discussions:
Presentation of the Chart prepared by the secretariat.
>> SECRETARIAT: Thank you, Mr. Chair. Indeed the chart which has been distributed deals with the -- with other issues and there are five specific issues listed on this chart. The first one refers to the beneficiaries of protection, term of protection, limitations and exceptions, technical protection measures, and rights management information.
Highlights of the discussion regarding transmission over computer network based on the second non paper (proposal by Japan)
I have received a request from KEI and I am ready to listen to their contributions at this point. KEI has the floor.
At the start of Day 2 of SCCR 32, it was clear that the Chair was hoping the committee would go into informals i.e. smaller groups with maybe only the group coordinator and a few invited delegates. No NGOs.
Here is the text under discussion (sccr/32/3)
III. RIGHTS TO BE GRANTED/PROTECTION
(1) Alternative A
(i) Broadcasting organizations shall have the right to authorize or prohibit the [simultaneous,
near-simultaneous] [and deferred] retransmission of their programme-carrying signal to the
public [[by any means] [/over any medium].
This is the text under discussion (sccr/32/3)II. OBJECT OF PROTECTION
(1) The protection granted under this Treaty extends only to programme-carrying signals
[including pre-broadcast signals] transmitted by, or on behalf of, a broadcasting [or a
cablecasting] organization[, but not to programmes contained therein].
(2) The provisions of this Treaty shall not provide any protection in respect of mere
(3) Alternative A
Notwithstanding paragraph (2) above, broadcasting [/cablecasting] organizations shall
EUROPEAN UNION: Thank you, Chair, for giving us the floor again. Just for clarity on our position, I think that on the definition of program, we would count ourselves as one in this delegation that see such addition as an obstacle to exercising rights under this treaty and that's why we maintain after your clarifications also that we would prefer to see it deleted from the definition of program the phrase that is authorized by the right holder for transmission.
UNITED STATES: Thank you, Mr. Chairman. Just to weigh in on a couple of the definitions that have been under discussion to date, so with respect to program carrying signal on the bracketed, the first bracketed language as originally transmitted and in any subsequent technical format, we agree with the E.U. that that is probably an important phrase to retain in as much as it makes clear that subsequent technical modifications of the signal will not result in the loss of protection of the originally transmitted signal.
ISSUE OF INCLUSION OR EXCLUSION OF CABLECASTING
Chair: Brazil, you still have the floor.
>> BRAZIL: Thank you, Chair.
Regarding a very quick follow-up to your question regarding -- as I mentioned, the proposal was presented and supported in 201 and 204 of the draft report and we understand it should be also reflected. We understand that this could be also a bridge of positions getting comfort to many Delegations that have concerns on this matter. These are the details that you have requested. Thank you, Chair.
>> CHAIR: Thank you for that.
The various groups statements from Asia and Pacific, Group B, Africa Group, GRULAC etc. were about the stated positions regarding the topics on the table i.e.the protection of broadcasting, cablecasting (and webcasting) organizations, the limitations and exceptions and for some their interest in new topics including the resale rights and the digital environment context study proposal. No surprises here.
The WIPO Director General Francis Gurry addressed the SCCR 32 Delegates at the opening of the meeting. His statement was substantive:
Today the Department of Health and Human Services held their annual WHA listening session. This year HHS sent an email the day prior announcing that the usual 3 minute allotment would be cut in half to 90 seconds. This decision caused several NGOs to not attend.
Astellas has claimed that patients taking Xtandi face very small co-payments. One patient living in Arizona contacted KEI with proof that Astellas' claims just aren't true. The patient, who is on Medicare, provided a copy of a summary of his expenses for the first quarter of of 2016.
His monthly patient co-payment is $441.97 a month.
2016: NIH FOIA office withholds all records related to exclusive license on HER2+ breast cancer treatment technology
Other KEI comments on NIH licenses are found here: http://keionline.org/nih-licenses
In response to a February request under the Freedom of Information Act (FOIA) for documents related to the grant of an exclusive patent license on a HER2+ breast cancer treatment technology, the National Institutes of Health (NIH) withheld in full all responsive records.
WHO CEWG 2016: Statement of Health Action International, Knowledge Ecology International and STOPAIDS
On Monday, 2 May 2016, the World Health Organization (WHO) convened the 2016 open-ended member states meeting of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG). The 2016 CEWG is chaired by Bhanu Pratap Sharma, Secretary, Ministry of Health and Family Welfare, Government of India. The Vice-Chair is Tania Dussey- Cavassini, Vice-Director General, Ambassador for Global Health, Federal Office of Public Health, Switzerland.
Rep. Lloyd Doggett keynote address at CAP drug pricing event highlights Xtandi, federal funding of pharmaceutical R&D
On April 26, 2016, Congressman Lloyd Doggett (D-Texas) delivered the keynote address at a panel discussion on drug pricing at the Center for American Progress, where he addressed the Federal government’s role in subsidizing drug development, ensuring affordable access at reasonable prices for U.S. citizens, industry practices related to monopoly pricing, and legislative solutions to promote rational and affordable drug prices.
The number of patents filed by China has accelerated over the last 15 years. According to WIPO, China represented just 1 percent of the fillings with the PCT in 2000. By 2015, China's share of PCT filing was 13.7 percent. We were interested to see how this increase in patent fillings related to China's growth in GDP.